The Crosstalk Between Gut Microbiota and Obesity and Related Metabolic Disorders

References

• Xu W, Yang Z, Zhou SF, Lu N. Posttranslational regulation of phosphatase and tensin homolog (PTEN) and its functional impact on cancer behaviors. Drug Des. Devel. Ther. 8, 1745 – 1751 (2014).
   PubMed Web of Science ®Google Scholar
• Ng M, Fleming T, Robinson M et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384 (9945 ), 766 – 781 (2014).
   PubMed Web of Science ®Google Scholar
• Xu WT, Yang Z, Lu NH. Roles of PTEN (phosphatase and tensin homolog) in gastric cancer development and progression. Asian Pac. J. Cancer Prev. 15 (1 ), 17 – 24 (2014).
   PubMedGoogle Scholar
• Myint PK, Kwok CS, Luben RN, Wareham NJ, Khaw KT. Body fat percentage, body mass index and waist-to-hip ratio as predictors of mortality and cardiovascular disease. Heart 100 (20 ), 1613 – 1619 (2014).
   PubMed Web of Science ®Google Scholar
• Noto H, Goto A, Tsujimoto T, Osame K, Noda M. Latest insights into the risk of cancer in diabetes. J. Diabetes Investig. 4 (3 ), 225 – 232 (2013).
   PubMed Web of Science ®Google Scholar
• Dietrich P, Hellerbrand C. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best Pract. Res. Clin. Gastroenterol. 28 (4 ), 637 – 653 (2014).
   PubMed Web of Science ®Google Scholar
• Tang WH, Wang Z, Levison BS et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N. Engl. J. Med. 368 (17 ), 1575 – 1584 (2013).
   PubMed Web of Science ®Google Scholar
• Hill JO. Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocr. Rev. 27 (7 ), 750 – 761 (2006).
   PubMed Web of Science ®Google Scholar
• Spor A, Koren O, Ley R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat. Rev. Microbiol. 9 (4 ), 279 – 290 (2011).
   PubMed Web of Science ®Google Scholar
• Rosenbaum M, Knight R, Leibel RL. The gut microbiota in human energy homeostasis and obesity. Trends Endocrin. Metab. 26 (9 ), 493 – 501 (2015).
   PubMed Web of Science ®Google Scholar
• Lederberg J. Infectious history. Science 288 (5464 ), 287 – 293 (2000).
   PubMed Web of Science ®Google Scholar
• Qin J, Li R, Raes J et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464 (7285 ), 59 – 65 (2010).
   PubMed Web of Science ®Google Scholar
• Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 486 (7402 ), 207 – 214 (2012).
   PubMed Web of Science ®Google Scholar
• Chen Y, Yang F, Lu H et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54 (2 ), 562 – 572 (2011).
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Hamady M, Yatsunenko T et al. A core gut microbiome in obese and lean twins. Nature 457 (7228 ), 480 – 484 (2009).
   PubMed Web of Science ®Google Scholar
• Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gut microbiota in nutrition and health. Nat. Rev. Gastroenterol. Hepatol. 9 (10 ), 577 – 589 (2012).
   PubMed Web of Science ®Google Scholar
• Sommer F, Backhed F. The gut microbiota – masters of host development and physiology. Nat. Rev. Microbiol. 11 (4 ), 227 – 238 (2013).
   PubMed Web of Science ®Google Scholar
• Lieverse RJ, Masclee AA, Jansen JB, Lam WF, Lamers CB. Obese women are less sensitive for the satiety effects of bombesin than lean women. Eur. J. Clin. Nutr. 52 (3 ), 207 – 212 (1998).
   PubMed Web of Science ®Google Scholar
• Crowell MD, Cheskin LJ, Musial F. Prevalence of gastrointestinal symptoms in obese and normal weight binge eaters. Am. J. Gastroenterol. 89 (3 ), 387 – 391 (1994).
   PubMed Web of Science ®Google Scholar
• Nosova T, Jokelainen K, Kaihovaara P et al. Aldehyde dehydrogenase activity and acetate production by aerobic bacteria representing the normal flora of human large intestine. Alcohol Alcohol. 31 (6 ), 555 – 564 (1996).
   PubMed Web of Science ®Google Scholar
• Cope K, Risby T, Diehl AM. Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology 119 (5 ), 1340 – 1347 (2000).
   PubMed Web of Science ®Google Scholar
• Nair S, Cope K, Risby TH, Diehl AM. Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis. Am. J. Gastroenterol. 96 (4 ), 1200 – 1204 (2001).
   PubMed Web of Science ®Google Scholar
• Backhed F, Ding H, Wang T et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl Acad. Sci. USA 101 (44 ), 15718 – 15723 (2004).
   PubMed Web of Science ®Google Scholar
• Kasai C, Sugimoto K, Moritani I et al. Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing. BMC Gastroenterol. 15, 100 (2015).
   PubMed Web of Science ®Google Scholar
• Bell DS. Changes seen in gut bacteria content and distribution with obesity: causation or association? Postgrad. Med. 127 (8 ), 863 – 868 (2015).
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhang M, Pang X, Zhao Y, Wang L, Zhao L. Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations. ISME J. 6 (10 ), 1848 – 1857 (2012).
   PubMed Web of Science ®Google Scholar
• De Vadder F, Kovatcheva-Datchary P, Goncalves D et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156 (1–2 ), 84 – 96 (2014).
   PubMed Web of Science ®Google Scholar
• Fei N, Zhao L. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J. 7 (4 ), 880 – 884 (2013).
   PubMed Web of Science ®Google Scholar
• Ridaura VK, Faith JJ, Rey FE et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341 (6150 ), 1241214 (2013).
   PubMed Web of Science ®Google Scholar
• Mar Rodriguez M, Perez D, Javier Chaves F et al. Obesity changes the human gut mycobiome. Sci. Rep. 5, 14600 (2015).
   PubMed Web of Science ®Google Scholar
• Zhang H, Dibaise JK, Zuccolo A et al. Human gut microbiota in obesity and after gastric bypass. Proc. Natl Acad. Sci. USA 106 (7 ), 2365 – 2370 (2009).
   PubMed Web of Science ®Google Scholar
• Tremaroli V, Karlsson F, Werling M et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab. 22 (2 ), 228 – 238 (2015).
   PubMed Web of Science ®Google Scholar
• Penney NC, Kinross J, Newton RC, Purkayastha S. The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review. Int. J. Obes. (Lond.) 39 (11 ), 1565 – 1574 (2015).
   PubMed Web of Science ®Google Scholar
• Clarke SF, Murphy EF, O'sullivan O et al. Targeting the microbiota to address diet-induced obesity: a time dependent challenge. PLoS ONE 8 (6 ), e65790 (2013).
   PubMed Web of Science ®Google Scholar
• Cotillard A, Kennedy SP, Kong LC et al. Dietary intervention impact on gut microbial gene richness. Nature 500 (7464 ), 585 – 588 (2013).
   PubMed Web of Science ®Google Scholar
• Den Besten G, Van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 54 (9 ), 2325 – 2340 (2013).
   PubMed Web of Science ®Google Scholar
• Xu J, Bjursell MK, Himrod J et al. A genomic view of the human-bacteroides thetaiotaomicron symbiosis. Science 299 (5615 ), 2074 – 2076 (2003).
   PubMed Web of Science ®Google Scholar
• Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 444 (7122 ), 1022 – 1023 (2006).
   PubMed Web of Science ®Google Scholar
• Cani PD, Amar J, Iglesias MA et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 (7 ), 1761 – 1772 (2007).
   PubMed Web of Science ®Google Scholar
• Cani PD, Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease. Curr. Pharm. Des. 15 (13 ), 1546 – 1558 (2009).
   PubMed Web of Science ®Google Scholar
• Lin HV, Frassetto A, Kowalik EJ Jr et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS ONE 7 (4 ), e35240 (2012).
   PubMed Web of Science ®Google Scholar
• Sleeth ML, Thompson EL, Ford HE, Zac-Varghese SE, Frost G. Free fatty acid receptor 2 and nutrient sensing: a proposed role for fibre, fermentable carbohydrates and short-chain fatty acids in appetite regulation. Nutr. Res. Rev. 23 (1 ), 135 – 145 (2010).
   PubMed Web of Science ®Google Scholar
• Samuel BS, Shaito A, Motoike T et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc. Natl Acad. Sci. USA 105 (43 ), 16767 – 16772 (2008).
   PubMed Web of Science ®Google Scholar
• Nadkarni P, Chepurny OG, Holz GG. Regulation of glucose homeostasis by GLP-1. Prog. Mol. Biol. Transl. Sci. 121, 23 – 65 (2014).
   PubMed Web of Science ®Google Scholar
• Cani PD, Possemiers S, Van De Wiele T et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58 (8 ), 1091 – 1103 (2009).
   PubMed Web of Science ®Google Scholar
• Joyce SA, Gahan CG. Bile acid modifications at the microbe-host interface: potential for nutraceutical and pharmaceutical interventions in host health. Annu. Rev. Food Sci. Technol. 7, 313 – 333 (2016).
   PubMed Web of Science ®Google Scholar
• Vrieze A, Out C, Fuentes S et al. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. J. Hepatol. 60 (4 ), 824 – 831 (2014).
   PubMed Web of Science ®Google Scholar
• Fiorucci S, Distrutti E. Bile acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders. Trends Mol. Med. 21 (11 ), 702 – 714 (2015).
   PubMed Web of Science ®Google Scholar
• Camilleri M, Gores GJ. Therapeutic targeting of bile acids. Am. J. Physiol. Gastrointest. Liver Physiol. 309 (4 ), G209 – G215 (2015).
   PubMed Web of Science ®Google Scholar
• Parseus A, Sommer N, Sommer F et al. Microbiota-induced obesity requires farnesoid X receptor. Gut doi:10.1136/gutjnl-2015-310283 (2016 ) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Ubeda M, Lario M, Munoz L et al. Obeticholic acid reduces bacterial translocation, restores intestinal barrier and inhibits inflammation in cirrhotic rats. J. Hepatol. 64 (5 ), 1049 – 1057 (2015).
   PubMed Web of Science ®Google Scholar
• Grootaert C, Van De Wiele T, Verstraete W, Bracke M, Vanhoecke B. Angiopoietin-like protein 4: health effects, modulating agents and structure-function relationships. Expert Rev. Proteomics 9 (2 ), 181 – 199 (2012).
   PubMed Web of Science ®Google Scholar
• Aronsson L, Huang Y, Parini P et al. Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS ONE 5 (9 ), e13087 (2010).
   PubMed Web of Science ®Google Scholar
• Korecka A, De Wouters T, Cultrone A et al. ANGPTL4 expression induced by butyrate and rosiglitazone in human intestinal epithelial cells utilizes independent pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 304 (11 ), G1025 – 1037 (2013).
   PubMed Web of Science ®Google Scholar
• Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nat. Rev. Gastroenterol. Hepatol. 9 (10 ), 599 – 608 (2012).
   PubMed Web of Science ®Google Scholar
• Wu GD, Chen J, Hoffmann C et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334 (6052 ), 105 – 108 (2011).
   PubMed Web of Science ®Google Scholar
• Moschen AR, Wieser V, Tilg H. Dietary factors: major regulators of the gut's microbiota. Gut Liver 6 (4 ), 411 – 416 (2012).
   PubMed Web of Science ®Google Scholar
• Carmody RN, Gerber GK, Luevano JM Jr et al. Diet dominates host genotype in shaping the murine gut microbiota. Cell Host Microbe 17 (1 ), 72 – 84 (2015).
   PubMed Web of Science ®Google Scholar
• Song MY, Wang JH, Eom T, Kim H. Schisandra chinensis fruit modulates the gut microbiota composition in association with metabolic markers in obese women: a randomized, double-blind placebo-controlled study. Nutr. Res. 35 (8 ), 655 – 663 (2015).
   PubMed Web of Science ®Google Scholar
• Bolnick DI, Snowberg LK, Hirsch PE et al. Individual diet has sex-dependent effects on vertebrate gut microbiota. Nat. Commun. 5, 4500 (2014).
   PubMed Web of Science ®Google Scholar
• Lichtman JS, Ferreyra JA, Ng KM, Smits SA, Sonnenburg JL, Elias JE. Host-microbiota interactions in the pathogenesis of antibiotic-associated diseases. Cell Rep. 14 (5 ), 1049 – 1061 (2016).
   PubMed Web of Science ®Google Scholar
• Franzosa EA, Hsu T, Sirota-Madi A et al. Sequencing and beyond: integrating molecular ‘omics’ for microbial community profiling. Nat. Rev. Microbiol. 13 (6 ), 360 – 372 (2015).
   PubMed Web of Science ®Google Scholar
• Candon S, Perez-Arroyo A, Marquet C et al. Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes. PLoS ONE 10 (5 ), e0125448 (2015).
   PubMed Web of Science ®Google Scholar
• Everard A, Belzer C, Geurts L et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl Acad. Sci. USA 110 (22 ), 9066 – 9071 (2013).
   PubMed Web of Science ®Google Scholar
• Lee H, Ko G. Effect of metformin on metabolic improvement and gut microbiota. Appl. Environ. Microbiol. 80 (19 ), 5935 – 5943 (2014).
   PubMed Web of Science ®Google Scholar
• Beysen C, Murphy EJ, Deines K et al. Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in Type 2 diabetes: a randomised controlled study. Diabetologia 55 (2 ), 432 – 442 (2012).
   PubMed Web of Science ®Google Scholar
• Mueller M, Thorell A, Claudel T et al. Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity. J. Hepatol. 62 (6 ), 1398 – 1404 (2015).
   PubMed Web of Science ®Google Scholar
• Sepe V, Distrutti E, Limongelli V, Fiorucci S, Zampella A. Steroidal scaffolds as FXR and GPBAR1 ligands: from chemistry to therapeutical application. Future Med. Chem. 7 (9 ), 1109 – 1135 (2015).
   PubMed Web of Science ®Google Scholar
• Petschow B, Dore J, Hibberd P et al. Probiotics, prebiotics, and the host microbiome: the science of translation. Ann. NY Acad. Sci. 1306, 1 – 17 (2013).
   PubMed Web of Science ®Google Scholar
• Sanders ME, Guarner F, Guerrant R et al. An update on the use and investigation of probiotics in health and disease. Gut 62 (5 ), 787 – 796 (2013).
   PubMed Web of Science ®Google Scholar
• Vrieze A, Van Nood E, Holleman F et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143 (4 ), 913 – 916, e917 (2012).
   PubMed Web of Science ®Google Scholar
• Udayappan SD, Hartstra AV, Dallinga-Thie GM, Nieuwdorp M. Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and Type 2 diabetes mellitus. Clin. Exp. Immunol. 177 (1 ), 24 – 29 (2014).
   PubMed Web of Science ®Google Scholar
• Cani PD, Knauf C, Iglesias MA, Drucker DJ, Delzenne NM, Burcelin R. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 55 (5 ), 1484 – 1490 (2006).
   PubMed Web of Science ®Google Scholar
• Kolida S, Meyer D, Gibson GR. A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans. Eur. J. Clin. Nutr. 61 (10 ), 1189 – 1195 (2007).
   PubMed Web of Science ®Google Scholar